Research Institute for Deseases of the Chest

Research output

Research output per year 1983 2004 2005 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2023

• 490 Article
• 41 Review article
• 8 Letter
• 4 Editorial
• 4 More
  • 3 Comment/debate
  • 1 Chapter

Research output per year

Research output per year

Search results

• 2021

  Immune-checkpoint kinetics for T cells in anti-MDA5 positive interstitial lung disease

  Suzuki, K., Yanagihara, T., Matsumoto, K., Chong, S. G., Ando, H., Ide, M., Arimura-Omori, M., Hata, K. & Hamada, N., Jan 1 2021, In: Rheumatology (United Kingdom). 60, 1, p. E14-E16

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Citation (Scopus)
• 2018

  Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer

  Otsubo, K., Seki, N., Nakanishi, Y. & Okamoto, I., Mar 1 2018, In: Annals of Oncology. 29, 3, p. 780-781 2 p.

  Research output: Contribution to journal › Letter › peer-review
  4 Citations (Scopus)

• Expression of PD-1 and PD-L1 on cytotoxic T lymphocytes and immune deficiency in a patient with adult T cell leukemia/lymphoma

  Yanagihara, T., Ikematsu, Y., Kato, K., Yonekawa, A., Ideishi, S., Tochigi, T., Sugio, T., Miyawaki, K., Tanaka, K., Harada, E., Hamada, N. & Nakanishi, Y., Feb 1 2018, In: Annals of Hematology. 97, 2, p. 359-360 2 p.

  Research output: Contribution to journal › Letter › peer-review
  8 Citations (Scopus)
• 2017

  Marked response to pembrolizumab in a patient with pulmonary pleomorphic carcinoma highly positive for PD-L1

  Ikematsu, Y., Yoneshima, Y., Ijichi, K., Tanaka, K., Harada, T., Oda, Y., Nakanishi, Y. & Okamoto, I., Oct 2017, In: Lung Cancer. 112, p. 230-231 2 p.

  Research output: Contribution to journal › Letter › peer-review
  22 Citations (Scopus)

• Poor pharmacological adherence to inhaled medicines compared with oral medicines in Japanese patients with asthma and chronic obstructive pulmonary disease

  Imamura, Y., Kawayama, T., Kinoshita, T., Sakazaki, Y., Yoshida, M., Takahashi, K., Fujii, K., Ando, M., Hoshino, T., Iwanaga, T., Kohrogi, H., Nakanishi, Y., Mukae, H., Watanabe, K., Hayashi, S., Kadota, J., Ii, T., Inoue, H., Tochigi, T., Fujita, J., & 1 othersNakamura, H., Jul 2017, In: Allergology International. 66, 3, p. 482-484 3 p.

  Research output: Contribution to journal › Letter › peer-review
  10 Citations (Scopus)

• Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer

  Ogata, H., Yamamoto, Y., Harada, T., Nakanishi, Y., Okamoto, I., Iwama, E., Iwama, E., Kato, K. & Oda, Y., May 2017, In: Journal of Thoracic Oncology. 12, 5, p. e46-e47

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  5 Citations (Scopus)

• Tumor-infiltrating lymphocyte-mediated pleuritis followed by marked shrinkage of metastatic kidney cancer of the chest wall during nivolumab treatment

  Yanagihara, T., Tanaka, K., ota, K., Kashiwagi, E., takeuchi, A., Tatsugami, K., Eto, M., Nakanishi, Y. & Okamoto, I., Aug 1 2017, In: Annals of Oncology. 28, 8, p. 2038-2039 2 p.

  Research output: Contribution to journal › Letter › peer-review
  11 Citations (Scopus)

• Two cases of late-onset secondary adrenal insufficiency after discontinuation of nivolumab

  Otsubo, K., Nakatomi, K., Furukawa, R., Ashida, K., Yoneshima, Y., Nakanishi, Y. & Okamoto, I., Dec 1 2017, In: Annals of Oncology. 28, 12, p. 3106-3107 2 p.

  Research output: Contribution to journal › Letter › peer-review
  12 Citations (Scopus)